$262.5 Million Funds Outbreak Analytics and Disease Modeling Network
The U.S. Centers for Disease Control and Prevention (CDC) recently announced it had granted 13 funding awards to establish a first-of-its-kind national network, the Outbreak Analytics and Disease Modeling Network (OADMN).
The OADMN's goal is to improve speed, accuracy, and use of data & analytics during health emergencies, which is an important step towards ensuring Americans have the information they need to keep themselves and their families safe during outbreaks.
Many of these awardees are leading a consortium of collaborators to design, prototype, test, and scale up advances in data modeling tools and technology that can be used to support public health decision-makers at all levels of government.
"The collaboration with our public health, private, and academic partners over the last year to advance the science of disease forecasting and deliver decision support to leaders has been instrumental in improving outbreak response," said Dr. Dylan George, Director, Center for Forecasting and Outbreak Analytics, in a press release on September 22, 2023.
The grantees will be organized into three categories of performance, supporting three priority program actions:
- Innovators: these grantees will develop methods, tools, technologies, and other products to support emergency response.
- Integrators: these grantees will take lessons learned and techniques from Innovators and test them in small-scale deployments.
- Implementors: these grantees will take tested best practices and scale up to larger jurisdictions and partners.
The funding 13 recipients comprising OADMN in September 2023 include:
The University of North Carolina at Chapel Hill
Kaiser Permanente Southern California
Carnegie Mellon University
University of Michigan School of Public Health
University of California, San Diego
University of Minnesota
University of Utah
International Responder Systems
The University of Texas at Austin
The Johns Hopkins University
Note: The OADMN effort is in addition to the U.S. government's Disease X initiative.